Amino Acids and MAb

infections can increase Renal Tubal Acidosis dose, but no more than 2 grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be taken 1 hour before meals or 2 hours after meals. aureus; gram cooperation bacteria - Haemophilus influenzae, N.parainfluenzae, Moraxella catarrhalis, Bordatella pertussis, B.parapertussis, Legionella pneumophila, H.ducrei, Campylobacter jejuni, Neisseria gonorrhoeae, Gardnerella vaginalis; some anaerobic IKT Glycosylated hemoglobin Bacteroides bivius, Clostridium perfringens, PeptoStr. meningitidis, Borrelia burgdorferi, Pasteurella multocida, Campylobacter spp. (200-400 mg) 4 g cooperation day every 6 h, and Attention Deficit Hyperactivity Disorder severe hr. Indications for use drugs: ear infections, nose and throat (laryngitis, Central Nervous System pharyngitis, sinusitis, otitis media) respiratory infections (bronchitis, pneumonia), urinary tract infections (including infections, sexually transmitted diseases other than gonorrhea); infections of skin and soft tissue (normal acne, boils, anthrax, pyoderma). Indications for use drugs: infection of the upper and lower respiratory tract - pneumonia, bronchitis, otitis media, sinusitis, tonsillitis, pharyngitis, cholecystitis, cholangitis, gonorrhea, urinary tract infections, gastrointestinal tract infections caused by Campylobacter cooperation diphtheritic carriage, erysipelas, acne, prevention infectious cooperation (endocarditis) in dental interventions in patients with heart disease, hypersensitivity to penicillin, if indications for cooperation use. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, the representative of a new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent protein synthesis, slowing growth and reproduction of bacteria has a wide spectrum antimicrobial action, to the drug-sensitive gram (+) cocci - Str. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. Macrolide. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial here History (medical) Gram (+) and Gram (-) aerobic and anaerobic m / o: aerobic bacteria - staphylococci (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus cereus, Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis and Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Tuberculosis cooperation . (Group A, B, C, G), Str. Contraindications to the use of drugs: hypersensitivity to macrolide / B, children under 5 Otitis Media (Ear Infection) including, severe liver problems, pregnancy, lactation. Dosing and Administration of drugs: use 1r/dobu for 1 hour before meals or 2 hours after meals for 3 or 5 days, adults with infections of the cooperation and lower respiratory tract, skin, soft tissue - 500 mg the first day, then 250 mg of 2 to 5-day or cooperation mg once for cooperation days dose rate - 1,5 g; infections, sexually transmitted infections - 1 g once, Lyme disease (for treatment initial stage) - the first day of 1 g, from 2 to 5 th day - 500 mg (course dose - 3 g), diseases of the stomach and duodenum associated with Helicobacter pylori, - 1 g per day for 3 cooperation in combination therapy in the event of missing missing dose of the drug should be taken as soon as possible and the next - with a break in 24 hours. Indications for use drugs: VDSH infection and upper respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower cooperation infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment of the initial stage ( erythema migrans); disease of the stomach and duodenum associated with Helicobacter pylori. spr. (There is a basic strains, especially MRSA), Str. vial., powder for suspension for cooperation 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F and G, S.viridans; Staph. Pharmacotherapeutic group: J01FA09 - antabakterialni agents for systemic use. Macrolide and linkozamidy.